{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T01:08:32Z","timestamp":1779066512393,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"DOI":"10.1038\/s44321-025-00306-3","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:41:03Z","timestamp":1759156863000},"page":"2850-2852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting mitochondrial Kv1.3 enables precise autoreactive T cell therapy for multiple sclerosis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6267-9472","authenticated-orcid":false,"given":"Stefano","family":"Pluchino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7938-7276","authenticated-orcid":false,"given":"Cory M","family":"Willis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"306_CR1","doi-asserted-by":"publisher","unstructured":"Angi B, Varanita T, Puthenparampil M, Scattolini V, Donadon M, Tavakoli M, Favero M, El Boustani M, Soddemann M, Biasutto L et al (2025) Selective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivo. EMBO Mol Med https:\/\/doi.org\/10.1038\/s44321-025-00307-2","DOI":"10.1038\/s44321-025-00307-2"},{"key":"306_CR2","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0605136103","volume":"103","author":"C Beeton","year":"2006","unstructured":"Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, Kolski-Andreaco A, Wei E, Grino A, Counts DR et al (2006) Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci USA 103:17414\u201317419","journal-title":"Proc Natl Acad Sci USA"},{"key":"306_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.865686","volume":"12","author":"J Capera","year":"2022","unstructured":"Capera J, Navarro-P\u00e9rez M, Moen AS, Szab\u00f3 I, Felipe A (2022) The mitochondrial routing of the Kv1.3 channel. Front Oncol 12:865686","journal-title":"Front Oncol"},{"key":"306_CR4","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/eji.201948223","volume":"49","author":"S De Biasi","year":"2019","unstructured":"De Biasi S, Simone AM, Bianchini E, Lo Tartaro D, Pecorini S, Nasi M, Patergnani S, Carnevale G, Gibellini L, Ferraro D et al (2019) Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients. Eur J Immunol 49:2204\u20132221","journal-title":"Eur J Immunol"},{"key":"306_CR5","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/brain\/awaa117","volume":"143","author":"NL Fransen","year":"2020","unstructured":"Fransen NL, Hsiao CC, van der Poel M, Engelenburg HJ, Verdaasdonk K, Vincenten MCJ, Remmerswaal EBM, Kuhlmann T, Mason MRJ, Hamann J et al (2020) Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions. Brain 143:1714\u20131730","journal-title":"Brain"},{"key":"306_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","volume":"175","author":"I Jelcic","year":"2018","unstructured":"Jelcic I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, Madjovski A, Ruhrmann S, Faigle W, Frauenknecht K et al (2018) Memory B cells activate brain-homing, autoreactive CD4(+) T cells in multiple sclerosis. Cell 175:85\u2013100.e123","journal-title":"Cell"},{"key":"306_CR7","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","volume":"17","author":"N Koch-Henriksen","year":"2021","unstructured":"Koch-Henriksen N, Magyari M (2021) Apparent changes in the epidemiology and severity of multiple sclerosis. Nat Rev Neurol 17:676\u2013688","journal-title":"Nat Rev Neurol"},{"key":"306_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ccell.2017.03.003","volume":"31","author":"L Leanza","year":"2017","unstructured":"Leanza L, Romio M, Becker KA, Azzolini M, Trentin L, Manag\u00f2 A, Venturini E, Zaccagnino A, Mattarei A, Carraretto L et al (2017) Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo. Cancer Cell 31:516\u2013531.e510","journal-title":"Cancer Cell"},{"key":"306_CR9","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/brain\/awt108","volume":"136","author":"M Mohme","year":"2013","unstructured":"Mohme M, Hotz C, Stevanovic S, Binder T, Lee JH, Okoniewski M, Eiermann T, Sospedra M, Rammensee HG, Martin R (2013) HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis. Brain 136:1783\u20131798","journal-title":"Brain"},{"key":"306_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn9361","volume":"10","author":"E Prosdocimi","year":"2024","unstructured":"Prosdocimi E, Carpanese V, Todesca LM, Varanita T, Bachmann M, Festa M, Bonesso D, Perez-Verdaguer M, Carrer A, Velle A et al (2024) BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway. Sci Adv 10:eadn9361","journal-title":"Sci Adv"},{"key":"306_CR11","doi-asserted-by":"publisher","first-page":"11094","DOI":"10.1073\/pnas.0501770102","volume":"102","author":"H Rus","year":"2005","unstructured":"Rus H, Pardo CA, Hu L, Darrah E, Cudrici C, Niculescu T, Niculescu F, Mullen KM, Allie R, Guo L et al (2005) The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc Natl Acad Sci USA 102:11094\u201311099","journal-title":"Proc Natl Acad Sci USA"},{"key":"306_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13046-022-02249-w","volume":"41","author":"F Severin","year":"2022","unstructured":"Severin F, Urbani A, Varanita T, Bachmann M, Azzolini M, Martini V, Pizzi M, Tos APD, Frezzato F, Mattarei A et al (2022) Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model. J Exp Clin Cancer Res 41:64","journal-title":"J Exp Clin Cancer Res"},{"key":"306_CR13","doi-asserted-by":"publisher","first-page":"14861","DOI":"10.1073\/pnas.0804236105","volume":"105","author":"I Szab\u00f3","year":"2008","unstructured":"Szab\u00f3 I, Bock J, Grassm\u00e9 H, Soddemann M, Wilker B, Lang F, Zoratti M, Gulbins E (2008) Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc Natl Acad Sci USA 105:14861\u201314866","journal-title":"Proc Natl Acad Sci USA"},{"key":"306_CR14","doi-asserted-by":"publisher","first-page":"12790","DOI":"10.1074\/jbc.M413548200","volume":"280","author":"I Szab\u00f2","year":"2005","unstructured":"Szab\u00f2 I, Bock J, Jekle A, Soddemann M, Adams C, Lang F, Zoratti M, Gulbins E (2005) A novel potassium channel in lymphocyte mitochondria. J Biol Chem 280:12790\u201312798","journal-title":"J Biol Chem"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00306-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00306-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00306-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:43:57Z","timestamp":1779065037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00306-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":14,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,10]]}},"alternative-id":["306"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00306-3","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SP is the founder, CSO, and shareholder (>5%) of CITC Ltd. CMW declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}